EMEA-000347-PIP02-16-M05
EMEA-000347-PIP02-16-M05
EMEA-000347-PIP02-16-M05
EMEA-000207-PIP01-08-M08
Referral: Hydroxyprogesterone caproate-containing medicinal products, hydroxyprogesterone caproate, associated names: Lentogest,Progesterone Retard Pharlon,Proluton Depot Article 31 referrals CMDh final position, 05/07/2024
2023 annual report of the European Medicines Agency
Pharmacovigilance fees payable to the European Medicines Agency
New Fee Regulation working arrangements
Draft VICH GL23 Studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing - Revision 2
Human medicines European public assessment report (EPAR): Sotyktu, deucravacitinib, Date of authorisation: 24/03/2023, Revision: 4, Status: Authorised
EMEA-003149-PIP01-21-M01
EMEA-003001-PIP01-21-M01